Perioperative Management of Patients with Prosthetic Heart Valves-A Narrative Review

被引:2
作者
Nath, Soumya Sankar [1 ]
Parashar, Samiksha [1 ]
机构
[1] Dr Ram Manohar Lohia Inst Med Sci, Dept Anesthesiol & Crit Care Med, Lucknow, Uttar Pradesh, India
关键词
Anticoagulation bridging therapy; heparin; infective endocarditis; low molecular weight heparin; neuraxial block; prosthetic heart valve; vitamin K antagonist; LEFT-VENTRICULAR FUNCTION; REGIONAL ANESTHESIA; EUROPEAN-SOCIETY; AMERICAN SOCIETY; TASK-FORCE; FOLLOW-UP; RECOMMENDATIONS; GUIDELINES; REPLACEMENT; DISEASE;
D O I
10.4103/aca.aca_109_21
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Worldwide, about 13% of the 200,000 annual recipients of prosthetic heart valves (PHV) present for various surgical procedures. Also, more and more females are opting for pregnancies after having PHV. All patients with PHV present unique challenges for the anesthesiologists, surgeons and obstetricians (in case of deliveries). They have to deal with the perioperative management of anticoagulation and a host of other issues involved. We reviewed the English language medical literature relevant to the different aspects of perioperative management of patients with PHV, particularly the guidelines of reputed societies that appeared in the last 20 years. Regression of cardiac pathophysiology following valve replacement is variable both in extent and timeline. The extent to which reverse remodeling occurs depends on the perioperative status of the heart. We discussed the perioperative assessment of patients with PHV, including focused history and relevant investigations with the inferences drawn. We examined the need for prophylaxis against infective endocarditis and management of anticoagulation in such patients in the perioperative period and the guidelines of reputed societies. We also reviewed the conduct of anesthesia, including general and regional anesthesia (neuraxial and peripheral nerve/plexus blocks) in such patients. Finally, we discussed the management of delivery in this group of high-risk patients. From the discussion of different aspects of perioperative management of patients with PHV, we hope to guide in formulating the comprehensive plan of management of safe anesthesia in such patients.
引用
收藏
页码:254 / 263
页数:10
相关论文
共 47 条
  • [1] [Anonymous], 2008, PROPHYLAXIS INFECT E
  • [2] Safety of Magnetic Resonance Imaging in Patients With Implanted Cardiac Prostheses and Metallic Cardiovascular Electronic Devices
    Baikoussis, Nikolaos G.
    Apostolakis, Efstratios
    Papakonstantinou, Nikolaos A.
    Sarantitis, Ioannis
    Dougenis, Dimitrios
    [J]. ANNALS OF THORACIC SURGERY, 2011, 91 (06) : 2006 - 2011
  • [3] Baumgartner H, 2018, EUR HEART J, V39, P1980, DOI [10.1093/eurheartj/ehx636, 10.1093/eurheartj/ehx391]
  • [4] Bioprosthetic Heart Valves, Thrombosis, Anticoagulation, and Imaging Surveillance
    Bax, Jeroen J.
    Delgado, Victoria
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (04) : 388 - 390
  • [5] Benzon HT, NEURAXIAL ANESTHESIA
  • [6] Botezatu B, 2020, AUTHOREA, DOI [10.22541/au.159986153.35535345, DOI 10.22541/AU.159986153.35535345]
  • [7] Recommendations for the management of patients after heart valve surgery
    Butchart, EG
    Gohlke-Bärwolf, C
    Antunes, MJ
    Tornos, P
    De Caterina, R
    Cormier, B
    Prendergast, B
    Iung, B
    Bjornstad, H
    Leport, C
    Hall, RJC
    Vahanian, A
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (22) : 2463 - 2471
  • [8] Choice of prosthetic heart valve in a developing country
    Choudhary, Shiv Kumar
    Talwar, Sachin
    Airan, Balram
    [J]. HEART ASIA, 2016, 8 (01) : 65 - 72
  • [9] Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients
    Daniels, Paul R.
    McBane, Robert D.
    Litin, Scott C.
    Ward, Sue A.
    Hodge, David O.
    Dowling, Nicole F.
    Heit, John A.
    [J]. THROMBOSIS RESEARCH, 2009, 124 (03) : 300 - 305
  • [10] Regional anaesthesia and antithrombotic drugs
    Davies, G.
    Checketts, M. R.
    [J]. BJA EDUCATION, 2012, 12 (01) : 11 - 16